BioVantra shares focused educational and clinical reference materials related to its diagnostic services and reporting approach. The resources below are written for urologists, pathologists, and the wider clinical teams involved in prostate and bladder cancer diagnosis and treatment.
Each topic gives a concise, clinically oriented overview of the underlying service and the reporting approach behind it. Content is written for use as reference rather than as promotional material.
A clinical overview of how cytologic and molecular information are reviewed and reported together in the IPCT service, and how that integration is designed to be clinically useful.
A reference to the interpretive framework used to describe cancer extent and lesion distribution, and how that framework relates to biopsy follow-up and treatment-planning discussions.
A reference to the non-invasive urine-based approach that combines cytology and molecular analysis in an integrated report, and how it is designed to support bladder cancer detection and surveillance.
An explanation of how digital review and synoptic reporting are used to support case examination, sign-out, and clearer communication among pathology and urology teams.
The resources are intended to be useful alongside day-to-day diagnostic work, not to act as a replacement for clinical judgment. Their purpose is to make BioVantra’s services and reporting easier to understand and to discuss.
Each topic gives a concise view of what a service is for, what it includes, and how its output is delivered, so the clinical context of BioVantra’s work is easier to follow.
Consistent language across the resources supports shared terminology in reports, referrals, and case discussions across the teams involved in a patient’s care.
Content is written to be useful as a point of reference for urologists, pathologists, and practice teams, rather than as promotional material.
The resources help clarify how cytomolecular testing, estimation and mapping, digital pathology, and urine-based testing fit into existing diagnostic workflows.
We work with urology practices and clinical teams involved in the diagnosis and treatment of prostate and bladder cancer. Share a little about your setting and a member of our team will follow up.